Developing trust in cancer care providers: clinician patient perspective

Developing trust in cancer care providers: clinician patient perspective

VJOncology

3 years
673 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Mark Schubert, DDS, MSD of Seattle Care Alliance Seattle, WA discusses what he as a dental clinician has learnt through his own experience of cancer care treatment, with the aim to translate this knowledge to other patients and hopefully improve their patient care. Dr. Schubert mentions the noticeable change in patients reaction after discovering that he shares the same experience of cancer care as a patient, a closer relationship is built alongside reducing anxiety, as patients feel he can relate to them. Dr. Schubert mentions having the ability to provide his patients with information on a more personal level, for instance discussing other non-oral side effects through personal experience rather than professional. He talks about preconceived thoughts regarding cancer and cancer care, which can be emotionally and subsequently mentally debilitating. Having a personal experience in cancer care, allows clinicians to bring to the patients encouragement that there are strategies to help them overcome their anxiety and progress with greater strength through treatment. Dr. Schubert emphasizes that patients must try to develop trust in their care providers, trying to unlearn some of their own anxious thoughts and replacing them with hope into their care providers, in order to achieve the best possible outcome. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) 2016 Annual Congress in Adelaide, Australia.
Up Next Autoplay
Long-Term Results from Phase 3 ALTA-1L Trial
Long-Term Results from Phase 3 ALTA-1L Trial
Category: Non-Small Cell Lung Cancer
5 Views
Cancer-News 14 hours
Mount Sinai Receives $1 Million Grant for Prostate Cancer Research
Mount Sinai Receives $1 Million Grant for Prostate Cancer Research
Category: News
2 Views
Cancer-News 16 hours
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Category: Kidney Cancer
7 Views
kidneycancer 17 hours
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Category: Kidney Cancer
0 Views
kidneycancer 18 hours
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Category: Kidney Cancer
3 Views
kidneycancer 1 day
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
Category: Acute Myelogenous Leukemia
4 Views
Cancer-News 1 day
CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial
CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial
Category: Breast Cancer
6 Views
Cancer-News 1 day
Modern Imaging Technology
Modern Imaging Technology
Category: Kidney Cancer
7 Views
kidneycancer 2 days
ASH Releases New Clinical Practice Guidelines on Immune Thrombocytopenia
ASH Releases New Clinical Practice Guidelines on Immune Thrombocytopenia
Category: News
2 Views
Cancer-News 2 days
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
Category: Kidney Cancer
7 Views
kidneycancer 3 days